{"disease":{"id":"moderate-dementia","name":"moderate dementia"},"drugs":{"marketed":[{"drug_id":"donepezil","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aricept","generic_name":"DONEPEZIL","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":"800","mechanism":"Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine."},{"drug_id":"galantamine-hydrobromide","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GALANTAMINE HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"benzgalantamine","indication_name":"mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zunveyl","generic_name":"BENZGALANTAMINE","company_name":"Alpha Cognition","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":56,"revenue":null,"mechanism":"Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors."},{"drug_id":"donepezil-aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Donepezil (Aricept)","company_name":"University of Virginia","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"Acetylcholinesterase Inhibitor","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"galantamine","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"namenda","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Namenda","company_name":"Inova Health Care Services","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"memantine","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Namenda","generic_name":"MEMANTINE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glutamate NMDA receptor; GRIN1/GRIN2A","drug_class":"N-methyl-D-aspartate Receptor Antagonist","quality_score":60,"revenue":null,"mechanism":"Namenda works by blocking the action of glutamate at the NMDA receptor, reducing excessive neural activity associated with Alzheimer's disease."},{"drug_id":"ebixa","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ebixa","company_name":"Konkuk University Medical Center","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aricept","company_name":"Eisai Korea Inc.","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01081743","title":"Effectiveness of Care Management in Alzheimer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Institut de Sante Publique, d'Epidemiologie et de Developpement","has_results":false},{"nct_id":"NCT04347668","title":"Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":266,"lead_sponsor_name":"Western University, Canada","has_results":false},{"nct_id":"NCT06471660","title":"Family Caregiver Online Survey (Dementia and Swallowing Difficulties)","phase":"","overall_status":"COMPLETED","enrollment_count":219,"lead_sponsor_name":"University of Oregon","has_results":false},{"nct_id":"NCT05165186","title":"Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05860127","title":"Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University of Massachusetts, Amherst","has_results":true},{"nct_id":"NCT05343611","title":"Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People","phase":"NA","overall_status":"UNKNOWN","enrollment_count":102,"lead_sponsor_name":"Massimo Venturelli, PhD","has_results":false},{"nct_id":"NCT03750409","title":"Assessing Feasibility of Prolonged Repetitive Near Infrared Light Stimulation in Early to Mid-Stage Dementia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Baylor Research Institute","has_results":false},{"nct_id":"NCT05561998","title":"Talking Mats as Decision Aid for Older People Living With Mild to Moderate Dementia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Göteborg University","has_results":false},{"nct_id":"NCT03462121","title":"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Regenera Pharma Ltd","has_results":false},{"nct_id":"NCT06632470","title":"Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":54,"lead_sponsor_name":"Baermed","has_results":false},{"nct_id":"NCT03890796","title":"Activity Scheduling for Older Adults With Dementia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"The Hong Kong Polytechnic University","has_results":false},{"nct_id":"NCT05844241","title":"The Effect of Auditory Interventions on Anxiety and Agitation in People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Lucid, Inc.","has_results":false},{"nct_id":"NCT03282877","title":"iCST Web-application for People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT04913818","title":"Effects of the Buddy-Up Dyadic Physical Activity Program on Health Outcomes of Care Dyads of Dementia: A Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04500847","title":"Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Butler Hospital","has_results":false},{"nct_id":"NCT04828434","title":"Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04550975","title":"Advanced Cognitive Stimulation Therapy (ACST)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04555629","title":"Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT07033468","title":"The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05527587","title":"The Effects of a Park Visit Program on Individuals With Dementia and Their Caregivers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT05004688","title":"A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Steven E Arnold, MD","has_results":true},{"nct_id":"NCT03773016","title":"Touchscreen Technology and Art for People With Dementia in Care Homes","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03591822","title":"Pilot Study of a Robot-assisted Intervention for the Management of Care-induced Pain in Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}